-
1
-
-
0027509977
-
Muscarinic receptor subtypes in airways
-
Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci. 1993; 52: 521-7.
-
(1993)
Life Sci
, vol.52
, pp. 521-527
-
-
Barnes, P.J.1
-
2
-
-
0025375882
-
Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung
-
Mak JC, Barnes PJ. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 1990; 141: 1559-68.
-
(1990)
Am Rev Respir Dis
, vol.141
, pp. 1559-1568
-
-
Mak, J.C.1
Barnes, P.J.2
-
3
-
-
0030442725
-
Muscarinic receptor subtypes and smooth muscle function
-
Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48: 531-65.
-
(1996)
Pharmacol Rev
, vol.48
, pp. 531-565
-
-
Eglen, R.M.1
Hegde, S.S.2
Watson, N.3
-
4
-
-
0029091990
-
Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea
-
Patel HJ, Barnes PJ, Tadjkarimi S, Yacoub MH, Belvisi MG. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. Am J Respir Crit Care Med 1995; 152: 872-8.
-
(1995)
Am J Respir Crit Care Med
, vol.152
, pp. 872-878
-
-
Patel, H.J.1
Barnes, P.J.2
Tadjkarimi, S.3
Yacoub, M.H.4
Belvisi, M.G.5
-
5
-
-
0025191514
-
Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle
-
Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3: 47-51.
-
(1990)
Pulm Pharmacol
, vol.3
, pp. 47-51
-
-
Roffel, A.F.1
Elzinga, C.R.2
Zaagsma, J.3
-
6
-
-
0029793984
-
On muscarinic control of neurogenic mucus secretion in ferret trachea
-
Ramnarine SL, Haddad EB, Khawaja AM, Mak JC, Rogers DF. On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 1996; 494: 577-86.
-
(1996)
J Physiol
, vol.494
, pp. 577-586
-
-
Ramnarine, S.L.1
Haddad, E.B.2
Khawaja, A.M.3
Mak, J.C.4
Rogers, D.F.5
-
7
-
-
0033534194
-
Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung disease
-
Disse B, Speck GA, Rominger KL, Witek TJ, Jr, Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 1999; 64: 457-64.
-
(1999)
Life Sci
, vol.64
, pp. 457-464
-
-
Disse, B.1
Speck, G.A.2
Rominger, K.L.3
Witek Jr, T.J.4
Hammer, R.5
-
8
-
-
0028179195
-
Characterization of {3H} 3Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: Radioligand binding and autoradiographic mapping
-
Haddad EB, Mak JC, Barnes PJ. Characterization of {3H} 3Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. Mol Pharmacol 1994; 45: 899-907.
-
(1994)
Mol Pharmacol
, vol.45
, pp. 899-907
-
-
Haddad, E.B.1
Mak, J.C.2
Barnes, P.J.3
-
9
-
-
0028886394
-
Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: A pharmacodynamic study in patients with chronic obstructive pulmonary disease
-
Maessens FPV, Smeets JJ, Sledsens TJH, et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease. Eur Respir J 1995; 8: 1506-13.
-
(1995)
Eur Respir J
, vol.8
, pp. 1506-1513
-
-
Maessens, F.P.V.1
Smeets, J.J.2
Sledsens, T.J.H.3
-
10
-
-
0027446311
-
-
Disse B, Reichl R, Speck G, Traunecker W, Ludwig Rominger KL. Life Sci 1993; 52: 537-544.
-
(1993)
Life Sci
, vol.52
, pp. 537-544
-
-
Disse, B.1
Reichl, R.2
Speck, G.3
Traunecker, W.4
Ludwig Rominger, K.L.5
-
11
-
-
0141990930
-
Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease
-
Calverly PM, Lee A, Towse L, et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003; 58: 855-60.
-
(2003)
Thorax
, vol.58
, pp. 855-860
-
-
Calverly, P.M.1
Lee, A.2
Towse, L.3
-
12
-
-
0037879081
-
Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses
-
Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003; 123: 1441-9.
-
(2003)
Chest
, vol.123
, pp. 1441-1449
-
-
Tashkin, D.1
Kesten, S.2
-
13
-
-
37849014833
-
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
-
Powrie DJ, Wilkinson TM, Donaldson GC, et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 2007; 30: 472-8.
-
(2007)
Eur Respir J
, vol.30
, pp. 472-478
-
-
Powrie, D.J.1
Wilkinson, T.M.2
Donaldson, G.C.3
-
14
-
-
34249338661
-
Acetylcholine-induced proliferation of fibroblast and myofibroblast in vitro is inhibited by tiotropium bromide
-
Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblast and myofibroblast in vitro is inhibited by tiotropium bromide. Life Sci 2007; 30: 2270-3.
-
(2007)
Life Sci
, vol.30
, pp. 2270-2273
-
-
Pieper, M.P.1
Chaudhary, N.I.2
Park, J.E.3
-
15
-
-
0030470881
-
New developments in anticholinergic drugs
-
Barnes P. New developments in anticholinergic drugs. Eur Respir Rev 1996; 6: 290-4.
-
(1996)
Eur Respir Rev
, vol.6
, pp. 290-294
-
-
Barnes, P.1
-
16
-
-
0024467177
-
Cholinergic bronchomotor tone in COPD: Estimates of its amount in comparison to normal
-
Gross NJA, Skorodins MS. Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison to normal. Chest 1989; 96: 984-7.
-
(1989)
Chest
, vol.96
, pp. 984-987
-
-
Gross, N.J.A.1
Skorodins, M.S.2
-
18
-
-
77953397289
-
-
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: workshop report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated Setember, 2005. [Date last accessed: January 13, 2007]. Available from: http: //www.goldcop.com/ GuidelineList.asp?!1=2&!=1
-
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: workshop report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated Setember, 2005. [Date last accessed: January 13, 2007]. Available from: http: //www.goldcop.com/ GuidelineList.asp?!1=2&!=1
-
-
-
-
19
-
-
0035131180
-
The bronchodilator test with increasing doses of terbutaline in chonic obstructive pulmonary disease patients
-
Rodríguez-Carballeira M, Heredia JL, Rué M, Quintana S, Gómez L. The bronchodilator test with increasing doses of terbutaline in chonic obstructive pulmonary disease patients. Pulm Pharmacol Ther 2001; 14: 61-5.
-
(2001)
Pulm Pharmacol Ther
, vol.14
, pp. 61-65
-
-
Rodríguez-Carballeira, M.1
Heredia, J.L.2
Rué, M.3
Quintana, S.4
Gómez, L.5
-
20
-
-
0032928281
-
Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease
-
Rodríguez-Carballeira M, Heredia JL, Gómez L, Quintana S, Viñas C. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 1999; 12: 43-8.
-
(1999)
Pulm Pharmacol Ther
, vol.12
, pp. 43-48
-
-
Rodríguez-Carballeira, M.1
Heredia, J.L.2
Gómez, L.3
Quintana, S.4
Viñas, C.5
-
21
-
-
33751516433
-
The bronchodilator test in chronic obstructive pulmonary disease: Interpretation methods
-
Rodríguez-Carballeira M, Heredia JL, Rué M, Quintana S, Almagro P. The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods. Respir Med 2007: 101: 34-42.
-
(2007)
Respir Med
, vol.101
, pp. 34-42
-
-
Rodríguez-Carballeira, M.1
Heredia, J.L.2
Rué, M.3
Quintana, S.4
Almagro, P.5
-
22
-
-
42949152368
-
Bronchodilator responsiveness in patients with COPD
-
Tashkin DP, Celli B, Decramer M., Liu D, Burkhart D, Cassino C. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008; 31: 742-50.
-
(2008)
Eur Respir J
, vol.31
, pp. 742-750
-
-
Tashkin, D.P.1
Celli, B.2
Decramer, M.3
Liu, D.4
Burkhart, D.5
Cassino, C.6
-
23
-
-
0034099036
-
Long-acting bronchodilation with once-daily dosing of tiotropium (spiriva) in stable chronic obstructive pulmonary disease
-
Littner MR, Ilowite JS, Tashkin DP, et al. Long-acting bronchodilation with once-daily dosing of tiotropium (spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1136-42.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 1136-1142
-
-
Littner, M.R.1
Ilowite, J.S.2
Tashkin, D.P.3
-
24
-
-
0036204964
-
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
-
Van Noord JA, Smeets JJ, Custers FL, et al. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 639-44.
-
(2002)
Eur Respir J
, vol.19
, pp. 639-644
-
-
Van Noord, J.A.1
Smeets, J.J.2
Custers, F.L.3
-
25
-
-
0036181956
-
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
-
Casaburi R, Mahler DA, Jones PW et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217-24.
-
(2002)
Eur Respir J
, vol.19
, pp. 217-224
-
-
Casaburi, R.1
Mahler, D.A.2
Jones, P.W.3
-
26
-
-
18244368740
-
Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1year treatment with tiotropium
-
Vincken W, Van Noord JA, Greefhorst AP, et al. Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1year treatment with tiotropium. Eur Respir J 2002; 19: 209-16.
-
(2002)
Eur Respir J
, vol.19
, pp. 209-216
-
-
Vincken, W.1
Van Noord, J.A.2
Greefhorst, A.P.3
-
27
-
-
0036305399
-
A 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol
-
Donohue JF, Van Noord JA, Bateman ED, et al. A 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.
-
(2002)
Chest
, vol.122
, pp. 47-55
-
-
Donohue, J.F.1
Van Noord, J.A.2
Bateman, E.D.3
-
28
-
-
0038366897
-
Health outcomes following treatment for six months with once daily tiotropium compared twice daily salmeterol in patients with COPD
-
Brusasco V, Hodder R, Miravitlles M, et al. Health outcomes following treatment for six months with once daily tiotropium compared twice daily salmeterol in patients with COPD. Thorax 2003; 58: 399-404.
-
(2003)
Thorax
, vol.58
, pp. 399-404
-
-
Brusasco, V.1
Hodder, R.2
Miravitlles, M.3
-
29
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celi B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
-
(2008)
N Engl J Med
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celi, B.2
Senn, S.3
-
30
-
-
77953407864
-
-
Cazzola M, Santus P, D'Adda A, Pizzolato S, Di Marco F. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Pulm Pharmacol Ther 2008. Web/URL PM: 19038356.
-
Cazzola M, Santus P, D'Adda A, Pizzolato S, Di Marco F. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Pulm Pharmacol Ther 2008. Web/URL PM: 19038356.
-
-
-
-
31
-
-
33645116728
-
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
-
van Noord JA, Aumann Jl, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006; 129: 509-17.
-
(2006)
Chest
, vol.129
, pp. 509-517
-
-
van Noord, J.A.1
Aumann, J.2
Janssens, E.3
-
32
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease
-
Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Annals Int Med 2007; 146: 545-56.
-
(2007)
Annals Int Med
, vol.146
, pp. 545-556
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
-
33
-
-
0033925684
-
Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease
-
Taube C, Lehnigk B, Paasch K, et al. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 216-20.
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 216-220
-
-
Taube, C.1
Lehnigk, B.2
Paasch, K.3
-
34
-
-
0032778472
-
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
-
O'Donell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-9.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 542-549
-
-
O'Donell, D.E.1
Lam, M.2
Webb, K.A.3
-
35
-
-
0034988166
-
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease
-
Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 63: 1395-9.
-
(2001)
Am J Respir Crit Care Med
, vol.63
, pp. 1395-1399
-
-
Marin, J.M.1
Carrizo, S.J.2
Gascon, M.3
-
36
-
-
0242721244
-
Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes
-
Celli B, Zu Wallack R, Wang S, et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 24: 1743-8.
-
(2003)
Chest
, vol.24
, pp. 1743-1748
-
-
Celli, B.1
Zu Wallack, R.2
Wang, S.3
-
37
-
-
2542603339
-
Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD
-
O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-40.
-
(2004)
Eur Respir J
, vol.23
, pp. 832-840
-
-
O'Donnell, D.E.1
Flüge, T.2
Gerken, F.3
-
38
-
-
77953433442
-
-
Gelb AF, Taylor CF, Cassino C, Shinar CM, Schein MJ, Zamel N. Pulm Pharmacol Ther 2009. Web/URL. PM: 19138754.
-
Gelb AF, Taylor CF, Cassino C, Shinar CM, Schein MJ, Zamel N. Pulm Pharmacol Ther 2009. Web/URL. PM: 19138754.
-
-
-
-
39
-
-
0021256105
-
The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
-
Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8.
-
(1984)
Chest
, vol.85
, pp. 751-758
-
-
Mahler, D.A.1
Weinberg, D.H.2
Wells, C.K.3
-
40
-
-
0034773257
-
Pulmonary Rehabilitation
-
British Thoracic Society Standards of Care Subcommittee on pulmonary Rehabilitation
-
British Thoracic Society Standards of Care Subcommittee on pulmonary Rehabilitation. Pulmonary Rehabilitation. Thorax 2001; 56: 827-34.
-
(2001)
Thorax
, vol.56
, pp. 827-834
-
-
-
41
-
-
0032937523
-
Pulmonary rehabilitation - 1999: Official statement of the American Thoracic Society
-
American Thoracic Society
-
American Thoracic Society. Pulmonary rehabilitation - 1999: official statement of the American Thoracic Society. Am J Respir Crit Care Med 1999; 159: 1666-82.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1666-1682
-
-
-
42
-
-
15844429415
-
Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD
-
Casaburi R, Kukafka D, Cooper CB, Witek TJ, Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127: 809-17.
-
(2005)
Chest
, vol.127
, pp. 809-817
-
-
Casaburi, R.1
Kukafka, D.2
Cooper, C.B.3
Witek Jr, T.J.4
Kesten, S.5
-
43
-
-
0036251766
-
Mortality after hospitalization for COPD
-
Almago P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL. Mortality after hospitalization for COPD. Chest 2002; 121: 1441-8.
-
(2002)
Chest
, vol.121
, pp. 1441-1448
-
-
Almago, P.1
Calbo, E.2
Ochoa de Echagüen, A.3
Barreiro, B.4
Quintana, S.5
Heredia, J.L.6
-
44
-
-
0023164742
-
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
-
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
-
(1987)
Ann Intern Med
, vol.106
, pp. 196-204
-
-
Anthonisen, N.R.1
Manfreda, J.2
Warren, C.P.3
Hershfield, E.S.4
Harding, G.K.5
Nelson, N.A.6
-
45
-
-
37849011194
-
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide
-
Wedzicha JA, Calverly MA, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177: 19-26.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 19-26
-
-
Wedzicha, J.A.1
Calverly, M.A.2
Seemungal, T.A.3
Hagan, G.4
Ansari, Z.5
Stockley, R.A.6
-
46
-
-
34447570984
-
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A systematic review with meta-analysis
-
Rodrigo GJ, Nannini LJ. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. Pulm Pharmacol Ther 2007; 20: 495-502.
-
(2007)
Pulm Pharmacol Ther
, vol.20
, pp. 495-502
-
-
Rodrigo, G.J.1
Nannini, L.J.2
-
47
-
-
33750029372
-
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis
-
Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax 2006; 61: 854-62.
-
(2006)
Thorax
, vol.61
, pp. 854-862
-
-
Barr, R.G.1
Bourbeau, J.2
Camargo, C.A.3
Ram, F.S.4
-
48
-
-
13444250953
-
The effects of a smoking cessation intervention on 14.5 year mortality: A randomized clinical trial
-
Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
-
(2005)
Ann Intern Med
, vol.142
, pp. 233-239
-
-
Anthonisen, N.R.1
Skeans, M.A.2
Wise, R.A.3
Manfreda, J.4
Kanner, R.E.5
Connett, J.E.6
-
49
-
-
48949103222
-
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study
-
Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-8.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 332-338
-
-
Celli, B.R.1
Thomas, N.E.2
Anderson, J.A.3
-
50
-
-
57349187989
-
Methodologic shortcomings of the INSPIRE randomized trial
-
Suissa S. Methodologic shortcomings of the INSPIRE randomized trial. Am J Respir Crit Care Med 2008: 178: 543-4.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 543-544
-
-
Suissa, S.1
-
51
-
-
0037111198
-
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: The COPE study
-
van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 2002; 166: 1358-63.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 1358-1363
-
-
van der Valk, P.1
Monninkhof, E.2
van der Palen, J.3
Zielhuis, G.4
van Herwaarden, C.5
-
52
-
-
48749129297
-
Survival with tiotropium compared to long-acting beta2-agonist in chronic obstructive pulmonary disease
-
Gershon AS, Wang L, To T, Luo J, Upshur RE. Survival with tiotropium compared to long-acting beta2-agonist in chronic obstructive pulmonary disease. COPD 2008; 5: 229-34.
-
(2008)
COPD
, vol.5
, pp. 229-234
-
-
Gershon, A.S.1
Wang, L.2
To, T.3
Luo, J.4
Upshur, R.E.5
-
53
-
-
0027962628
-
Effects of smoking intervention and the use of an inhales anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study
-
Anthonissen NR, Connet JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhales anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272: 1497-1505.
-
(1994)
JAMA
, vol.272
, pp. 1497-1505
-
-
Anthonissen, N.R.1
Connet, J.E.2
Kiley, J.P.3
-
54
-
-
11844265905
-
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
-
Anzueto A, Tashkin D, Menjoge S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2005; 18: 75-81.
-
(2005)
Pulm Pharmacol Ther
, vol.18
, pp. 75-81
-
-
Anzueto, A.1
Tashkin, D.2
Menjoge, S.3
-
55
-
-
0034727828
-
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
-
The Lung Health Study Research Group
-
The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-9.
-
(2000)
N Engl J Med
, vol.343
, pp. 1902-1909
-
-
-
56
-
-
0345188819
-
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
-
Paweles RA, Löfdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948-53.
-
(1999)
N Engl J Med
, vol.340
, pp. 1948-1953
-
-
Paweles, R.A.1
Löfdahl, C.G.2
Laitinen, L.A.3
-
57
-
-
0034643610
-
Randomised, double blind placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
-
Burge PS, Calverly PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-303.
-
(2000)
BMJ
, vol.320
, pp. 1297-1303
-
-
Burge, P.S.1
Calverly, P.M.2
Jones, P.W.3
Spencer, S.4
Anderson, J.A.5
Maslen, T.K.6
-
58
-
-
20944433417
-
-
Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365: 1552-60. (Erratum, Lancet 2005; 366: 984).
-
Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365: 1552-60. (Erratum, Lancet 2005; 366: 984).
-
-
-
-
59
-
-
33845938174
-
Pooled clinical trial analysis of tiotropium safety
-
Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest 2006; 130: 1695- 1703.
-
(2006)
Chest
, vol.130
, pp. 1695-1703
-
-
Kesten, S.1
Jara, M.2
Wentworth, C.3
Lanes, S.4
-
60
-
-
52449106502
-
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
-
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 1439-50.
-
(2008)
JAMA
, vol.300
, pp. 1439-1450
-
-
Singh, S.1
Loke, Y.K.2
Furberg, C.D.3
-
62
-
-
34248382008
-
Cardiovascular an respiratory hospitalizations and mortality among users of tiotropium in Denmark
-
de Luise C, Lanes SF, Jacobsen J, Pedersen L, Sorensen HT. Cardiovascular an respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol 2007; 22: 267-72.
-
(2007)
Eur J Epidemiol
, vol.22
, pp. 267-272
-
-
de Luise, C.1
Lanes, S.F.2
Jacobsen, J.3
Pedersen, L.4
Sorensen, H.T.5
-
63
-
-
0029993821
-
Prolonged effect of tiotropium bromide on metacholine-induced bronchoconstriction in asthma
-
O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on metacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154: 876-80.
-
(1996)
Am J Respir Crit Care Med
, vol.154
, pp. 876-880
-
-
O'Connor, B.J.1
Towse, L.J.2
Barnes, P.J.3
-
64
-
-
34247645201
-
A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
-
Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007; 101: 1218-28.
-
(2007)
Respir Med
, vol.101
, pp. 1218-1228
-
-
Fardon, T.1
Haggart, K.2
Lee, D.K.3
Lipworth, B.J.4
-
65
-
-
33646556210
-
Anticholinergic agents in asthma: Chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling
-
Kanazawa H. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling. Curr Opin Pulm Med 2006; 12: 60-7.
-
(2006)
Curr Opin Pulm Med
, vol.12
, pp. 60-67
-
-
Kanazawa, H.1
-
66
-
-
36349023217
-
Improvements with tiotropium in COPD patients with concomitant asthma
-
Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2008; 102: 50-6.
-
(2008)
Respir Med
, vol.102
, pp. 50-56
-
-
Magnussen, H.1
Bugnas, B.2
van Noord, J.3
Schmidt, P.4
Gerken, F.5
Kesten, S.6
-
67
-
-
49649102385
-
Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype
-
Iwamoto H, Yokoyama A, Shiota N, et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008; 31: 1379-82.
-
(2008)
Eur Respir J
, vol.31
, pp. 1379-1382
-
-
Iwamoto, H.1
Yokoyama, A.2
Shiota, N.3
|